Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...
Zacks Investment Research on MSN
DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised
DexCom, Inc. DXCM reported third-quarter 2025 adjusted earnings per share (EPS) of 61 cents, which beat the Zacks Consensus ...
After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
DexCom posts Q3 revenue of $1.21 billion, beating estimates and raising 2025 guidance as analysts expect strong sales and margin improvement ahead.
Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...
Is your feature request related to a problem? Please describe. If Dexcom Share is configured in the G6 CGM setup, and the transmitter ID is wrong or not updated upon change of transmitted, the user ...
DANVILLE, CA, UNITED STATES, April 13, 2023/EINPresswire.com/ -- GenieMD, Inc. (“GenieMD”), a leader in virtual care platform and services, recognized by Frost ...
After plenty of anticipation — and a bit of waiting — the next-generation Dexcom G7 continuous glucose monitor is finally here. In mid-2021, Dexcom (Nasdaq:DXCM) CEO Kevin Sayer told Drug Delivery ...
The Dexcom G7 continuous glucose monitoring (CGM) system has been granted a CE Mark (Conformité Européenne), which means it is approved for use in people with diabetes in Europe aged 2 years and older ...
The Australian government has expanded the subsidised access to the latest generation of Dexcom's continuous glucose monitoring device, Dexcom G6, for diabetic Australians. This comes as the previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback